NASA Hangout: All Eyes on the Sun
On March 29, 2014, an X-class flare burst off the right side of the sun . . . and NASA was watching. Coordinating their observations, four NASA observatories and one ground-based telescope...
By: NASA Goddard
More here:
From Buzz Lightyear to Tron, this is NASA #39;s new prototype spacesuit: 90 Seconds on The Verge
NASA let the internet choose the design of its next Z-2 prototype spacesuit, and the internet chose Tron... or maybe it #39;s Daft Punk #39;s bodyguard... or the Hunchback of Alpha Centauri... or a...
By: The Verge
The rest is here:
From Buzz Lightyear to Tron, this is NASA's new prototype spacesuit: 90 Seconds on The Verge - Video
What #39;s the ROI on NASA?
Is the money we spend on NASA well spent? Find out what NASA #39;s ROI (Return on Investment) is in this Cosmic Queries "Behind the Scenes" video featuring guest host Bill Nye the Science Guy,...
By: StarTalk Radio
View original post here:
Is This An Alien Grey? Strange Alien Creature Spotted In NASA Enceladus Image
Strange Alien Creature In Cocoon Spotted in NASA Enceladus Image. Is This An Alien Grey? Or is this a glimpse of a different kind of Alien ? Saturn moon anomaly. The original image is high...
By: extraterrestrial tv
View post:
Is This An Alien Grey? Strange Alien Creature Spotted In NASA Enceladus Image - Video
NASA has announced the selection of three US companies to develop a lunar lander to deliver payloads to the Moons surface. The three companies, Astrobotic Technology, Masten Space Systems, and Moon Express, wont be receiving any funds, but will negotiate with the space agency for a partnership to exchange technical expertise and help promote the private space sector.
The partnerships are part of NASAs Lunar Cargo Transportation and Landing by Soft Touchdown (Lunar CATALYST) initiative. Like the Commercial Crew Program (CCP), where NASA called on private industry to come up with a replacement for the Space Shuttle to carry crews and cargo to the International Space Station, the CATALYST initiative is a way for the agency to get around shrinking budgets or lack of government interest by teaming with private partners.
The Moon Express MX-1 Lander (Image: Moon Express, Inc)
Operated under the Advanced Exploration Systems Division of NASA's Human Exploration and Operations Mission Directorate, Lunar CATALYSTs goal is to develop a reliable and cost-effective commercial robotic lunar lander for carrying cargo to the lunar surface. The idea is that these landers would be used for commercial purposes, such as mining helium-3, cryogenic manufacturing, solar power generation or spacecraft refueling, while helping out NASA and other researchers on scientific missions, such as sample returns, prospecting, and technology demonstrations.
Astrobotic Technologys Griffin lander (Image: Astrobotic Technology)
Under the partnership agreement, NASA will provide the three companies with technical expertise, access to test facilities, and the loan of equipment and software for three years to help with lander development.
"NASA is making advances to push the boundaries of human exploration farther into the solar system, including to an asteroid and Mars, and continues to spur development in the commercial space sector," says Jason Crusan, director of the Advanced Exploration Systems Division at NASA Headquarters in Washington. "Robotic missions to the moon have revealed the existence of local resources, including oxygen and water, which may be highly valuable for exploration of the solar system. The potential to use the lunar surface in partnership with our international and commercial partners may allow these resources to be characterized and used to enable future exploration and pioneering."
Source: NASA
Continued here:
A NASA spacecraft designed to make precise measurements of carbon dioxide in Earths atmosphere is at Vandenberg Air Force Base, Calif., to begin final preparations for launch.
The Orbiting Carbon Observatory-2 arrived Wednesday at its launch site on California's central coast after traveling from Orbital Sciences Corp.'s Satellite Manufacturing Facility in Gilbert, Ariz. The spacecraft now will undergo final tests and then be integrated on top of a United Launch Alliance Delta II rocket in preparation for a planned July 1 launch.
The observatory is NASA's first satellite mission dedicated to studying carbon dioxide, a critical component of Earths carbon cycle that is the leading human-produced greenhouse gas driving changes in Earth's climate. It replaces a nearly identical spacecraft lost due to a rocket launch mishap in February 2009.
OCO-2 will provide a new tool for understanding both the sources of carbon dioxide emissions and the natural processes that remove carbon dioxide from the atmosphere, and how they are changing over time. Since the start of the Industrial Revolution more than 200 years ago, the burning of fossil fuels, as well as other human activities, have led to an unprecedented buildup in this greenhouse gas, which is now at its highest level in at least 800,000 years. Human activities have increased the level of carbon dioxide by more than 25 percent in just the past half century.
Greenhouse gases, such as carbon dioxide, trap the sun's heat within Earth's atmosphere, warming it and keeping it at habitable temperatures. However, scientists have concluded that increases in carbon dioxide resulting from human activities have thrown Earth's natural carbon cycle off balance, increasing global temperatures and changing the planet's climate.
While scientists understand carbon dioxide emissions resulting from burning fossil fuels and can estimate their quantity quite accurately, their understanding of carbon dioxide from other human-produced and natural sources is relatively less quantified. Atmospheric measurements collected at ground stations indicate less than half of the carbon dioxide humans emit into the atmosphere stays there. The rest is believed to be absorbed by the ocean and plants on land.
But the locations and identity of the natural "sinks" absorbing this carbon dioxide currently are not well understood. OCO-2 will help solve this critical scientific puzzle. Quantifying how the natural processes are helping remove carbon from the atmosphere will help scientists construct better models to predict how much carbon dioxide these sinks will be able to absorb in the future.
The missions innovative technologies will enable space-based measurements of atmospheric carbon dioxide with the sensitivity, resolution and coverage needed to characterize the sources of carbon dioxide emissions and the natural sinks that moderate their buildup, at regional scales, everywhere on Earth. The mission's data will help scientists reduce uncertainties in forecasts of how much carbon dioxide is in the atmosphere and improve the accuracy of global climate change predictions.
In addition to measuring carbon dioxide, OCO-2 will monitor the "glow" of the chlorophyll contained within plants, a phenomenon known as solar-induced chlorophyll fluorescence, opening up potential new applications for studying vegetation on land. NASA researchers, in collaboration with Japanese and other international colleagues, have discovered that data from Japan's GOSAT (Greenhouse gases observing SATellite, also known as Ibuki in Japan), along with other satellites, including OCO-2, can help monitor this signature of photosynthesis on a global scale.
The observatory will fly in a 438-mile (705-kilometer) altitude, near-polar orbit in formation with the five other satellites that are part of the Afternoon, or "A-Train" Constellation. This international constellation of Earth-observing satellites circles Earth once every 98 minutes in a sun-synchronous orbit that crosses the equator near 1:30 p.m. local time and repeats the same ground track every 16 days. OCO-2 will be inserted at the head of the A-Train. Once in this orbit, OCO-2 is designed to operate for at least two years. This coordinated flight formation will enable researchers to correlate OCO-2 data with data from other NASA and partner spacecraft.
See the original post:
NASA announced Wednesday the selection of three U.S. companies to negotiate no-funds exchanged partnership agreements with the agency to advance lander capabilities that will enable delivery of payloads to the surface of the moon, as well as new science and exploration missions of interest to NASA and scientific and academic communities.
The selected companies are: -- Astrobotic Technology, Inc., Pittsburgh -- Masten Space Systems, Inc., Mojave, Calif. -- Moon Express, Inc., Moffett Field, Calif.
NASA made the selections following a January solicitation for proposals. The agency now will negotiate no-funds exchanged Space Act Agreements with the companies as part of the agency's Lunar Cargo Transportation and Landing by Soft Touchdown (Lunar CATALYST) initiative. NASA's contributions for an estimated three-year period may include technical expertise, access to agency test facilities, equipment loans and/or software for lander development and testing.
"NASA is making advances to push the boundaries of human exploration farther into the solar system, including to an asteroid and Mars, and continues to spur development in the commercial space sector," said Jason Crusan, director of the Advanced Exploration Systems Division at NASA Headquarters in Washington. "Robotic missions to the moon have revealed the existence of local resources, including oxygen and water, which may be highly valuable for exploration of the solar system. The potential to use the lunar surface in partnership with our international and commercial partners may allow these resources to be characterized and used to enable future exploration and pioneering."
Commercial lunar transportation capabilities could support science and exploration objectives such as sample returns, geophysical network deployment, resource prospecting, and technology advancements.
The Advanced Exploration Systems Division of NASA's Human Exploration and Operations Mission Directorate manages Lunar CATALYST. Advanced Exploration Systems pioneers new approaches for rapidly developing prototype systems, demonstrating key capabilities and validating operational concepts for future human missions beyond Earth orbit.
As NASA works with U.S. industry to develop the next generation of U.S. spaceflight services, the agency also is developing the Orion spacecraft and Space Launch System (SLS), a crew capsule and heavy-lift rocket to provide an entirely new capability for human exploration. Designed for launching spacecraft for crew and cargo missions, SLS and Orion will expand human presence beyond low-Earth orbit and enable new missions of exploration across the solar system, including to a near-Earth asteroid and Mars. For more information about the Lunar CATALYST initiative, visit:
http://www.nasa.gov/lunarcatalyst
Read this article:
NASA Selects Partners for U.S. Commercial Lander Capabilities
Rice University #39;s online course Nanotechnology: The Basics
Small Talk with Professors Douglas Natelson, Vicki Colvin and Daniel Mittleman In this interview with Dr. Douglas Natelson, Rice University Department of Physics and Astronomy, Drs. Colvin...
By: Rice University
More:
Rice University's online course Nanotechnology: The Basics - Video
By Estel Grace Masangkay
Johns Hopkins biomedical engineers and neurosurgeons announced that they have successfully manufactured biodegradable nanoparticles that are able to carry death genes to brain cancer cells in mice. The scientists likened the DNA-carrying nanoparticles to Trojan horses that target and enter tumor cells.
The team reported that results of their proof of principle experiment indicate that such Trojan horse nanoparticles loaded with death genes might one day be used in patients with brain cancer during neurosurgery. The nanoparticles will allow normal brain tissue to stay unharmed while they selectively targetand kill any remaining tumor cells.
Jordan Green, assistant professor of biomedical engineering and neurosurgery at the Johns Hopkins University School of Medicine, said, In our experiments, our nanoparticles successfully delivered a test gene to brain cancer cells in mice, where it was then turned on. We now have evidence that these tiny Trojan horses will also be able to carry genes that selectively induce death in cancer cells, while leaving healthy cells healthy.
Professor Greens lab specializes in manufacturing tiny, round particles made of biodegradable plastic which are enhanced and sent out to complete medical missions. Professor Greens team produced dozens of different nanoparticles in order to test their ability to carry DNA sequences to cells used in the experiment.
The researchers focused on the most deadly and aggressive form of brain cancer, glioblastomas. Median survival time for glioblastomas is only 14.6 months with chemotherapy and radiation.
Improvements in treatment will only be achieved when cancer cells currently resistant to treatment are able to be destroyed, said Alfredo Quiones-Hinojosa, professor of neurosurgery at the Johns Hopkins University School of Medicine and a member of the research team. It is exciting to have found a way to selectively target gene delivery to cancer cells. Its a method that is much more feasible and safer for patients than traditional gene therapy, which uses modified viruses to carry out the treatment, said Professor Quiones-Hinojosa.
A summary of the researchers study results was published online in the journal ACS Nano.
Continued here:
Trojan Horse' Nanoparticles Deliver Death Genes To Brain Cancer Cells
Attorneys Russ Moore and his son Russel Moore recently earned Volunteers of the Year for the Rockdale County Family Law Information Center. (Staff Photo: Karen Rohr)
CONYERS As the saying goes, time is money, but two local attorneys decided time can also equate to a chance to assist local citizens, even if compensation isnt involved.
Russel Moore and his father, Russ Moore, of the law office Nation, Moore and Associates on Bank Street in Olde Town Conyers recently shared the honor of the 2013 Volunteer Attorney of the Year for the Family Law Information Center. The Center provides free consultations to those citizens needing information and guidance related to family law issues like divorce or adoption. Volunteer attorneys make themselves available for the one-time, 30-minute meetings each Friday from 9:30 a.m. to noon.
The Center is coordinated by the Rockdale County Superior Court Clerks Civil Division, and attorneys meet with members of the public in the Rockdale County Courthouse Law Library.
Russel Moore said he estimates he and his father invest one Friday every one to two months, but sometimes more if other attorneys cancel.
If someone bows out, were more than happy to fill in. Its a way to give back to the community and you always meet with some interesting people while youre there, he said. Our experience is most often once they get an answer, it keeps them out of court so it makes their path through the court system easier.
Moore said that divorce is the most popular legal matter that people want to discuss, and that for some couples who have no children, proceeding through the paperwork themselves, without having to go to court, is a solution. For those with children, hiring an attorney is most likely necessary due to child custody issues.
In their law practice, the Moores handle about 80 percent family law cases. Sometimes they take on cases they hear at the Center as pro-bono work if a person doesnt have the resources to hire an attorney. Alternately, sometimes people who are aided by the Center choose to hire them for work.
The Moores have been volunteers at the Center since June 2013. Russel Moore said that the volunteer attorneys not only point citizens in the right direction when it comes to pursuing legal matters, but that the time the volunteers take with the citizens alleviates stress on staff at the Clerk of Courts office.
Clerk of Courts office, attorneys and citizens all reap the benefits from the Center, he said.
Here is the original post:
30.04.2014 - (idw) Max-Delbrck-Centrum fr Molekulare Medizin (MDC) Berlin-Buch
Four researchers from the U.S., Italy and Germany, among them Professor Nikolaus Rajewsky from the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, have been awarded a grant of more than 1.2 million dollars from the Human Frontier Science Program Organization (HFSPO), Strasbourg, France, for a project in cancer research.* In collaboration with Professor Brian Brown from the Mount Sinai School of Medicine, New York, USA, the researchers aim to decipher non-coding RNA regulatory networks and their role in the onset of cancer. In 2014, HFSPO is awarding about 35 million dollars to the 34 winning teams that have been selected in a rigorous selection procedure out of 844 proposals. A non-coding RNA (nc-RNA) is an RNA molecule which is not translated into protein. The geneticist Professor Brown and systems biologist Professor Rajewsky, together with their collaboration partners in Rome and Boston, aim to shed light on the complex interactions and possible competition situations of non-coding RNAs. These provide fundamental insights into the function of gene-regulatory networks and their role in the pathogenesis of cancer and other diseases. To achieve this, an interdisciplinary approach is necessary for which the team combines complementary expertise and applies molecular biological, genetic and biochemical methods along with computer-based methods.
*Deciphering non-coding RNA regulatory networks and their role in cancer cell biology
Contact: Barbara Bachtler Press Department Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch in the Helmholtz Association Robert-Rssle-Strae 10 13125 Berlin Germany Phone: +49 (0) 30 94 06 - 38 96 Fax: +49 (0) 30 94 06 - 38 33 e-mail: presse@mdc-berlin.de http://www.mdc-berlin.de/ Weitere Informationen:http://www.hfsp.org/about-us/press-and-media-centre/news-items/hfsp-2014-awards-...
See the article here:
PUBLIC RELEASE DATE:
30-Apr-2014
Contact: Catherine Davidge cdavidge@amp.org 301-634-7400 Association for Molecular Pathology
The Association for Molecular Pathology (AMP) announced today that Francis S. Collins, MD, PhD, Director of the National Institutes of Health (NIH), will give a special address at the AMP 2014 Annual Meeting and 20th Anniversary Celebration. The meeting will be held November 12-15, 2014 at the Gaylord National Resort and Convention Center in National Harbor, MD (just outside of Washington, DC). The theme of the event is "Realizing the Dream of Precision Medicine." Dr. Collins will address the 2,000+ molecular diagnostic professionals in attendance on the evening of November 12. "We are incredibly honored to have Dr. Collins with us," said Elaine Lyon, MD, PhD, AMP President, "he pioneered the field of genomics and continues to help create the landscape for precision medicine and the work of AMP members."
AMP will be celebrating the progress made in genomic medicine over the past two decades with the keen insight of one of the luminaries in the field. "Dr. Collins was the first recipient of the AMP Award for Excellence in Molecular Diagnostics. It's fitting that Dr. Collins joins AMP for its 20th Anniversary Celebration to commemorate this milestone," said Charles E. Hill, MD, PhD, Chair, Program Committee. "We look forward to hearing his address and to having him with us as we celebrate 20 years of AMP."
Registration for the AMP 2014 Annual Meeting and 20th Anniversary Celebration opens in mid-May. The preliminary program is available online now at: http://www.amp.org/meetings/2014/preliminary_program.cfm.
###
ABOUT AMP:
The Association for Molecular Pathology (AMP) was founded in 1994 to provide structure and leadership to what was, at the time, the newly-emerging field of molecular diagnostics. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP has established itself as the primary resource for expertise, education, and collaboration on what is now one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels; ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.
AMP's 2,300+ members include individuals from academic and community medical centers, government, and industry; including, basic and translational scientists, pathologist and doctoral scientist laboratory directors, medical technologists, and trainees. AMP members span the globe with members in more than 45 countries and a growing number of AMP International Affiliate Organizations. The number of AMP members is growing rapidly; they are united by the goal of advancing the science and implementation of molecular and genomic laboratory medicine. For more information, please visit http://www.amp.org.
Read the original:
Francis S. Collins, M.D., Ph.D., to speak at AMP 2014 Annual Meeting
Transcendence promises something a little different in that the computer in question is a melding of machine and man.
FILM Transcendence (M) 2.5 stars Johnny Depp, Rebecca Hall, Paul Bettany Directed by Wally Pfister REVIEW MARK NAGLAZAS
After the sensuality and subtlety of Her, in which Scarlett Johansson plays an operating system with a mind of its own, we're now back in the more conventional sci-fi universe with Transcendence, in which computers are depicted not as helpers to mankind but their enemy.
However, Transcendence promises something a little different in that the computer in question is a melding of machine and man, a combination of the cold-blooded logic of a system built on zeroes and ones and the capriciousness and flaws of even the most logical of humans.
The man in question is a visionary scientist named Will Caster who is working towards creating a computer that will achieve "singularity" or "transcendence", a machine that will bring together the accumulated knowledge of all mankind and the ability to think and make its own decisions.
Indeed, Max goes so far as to believe that such a machine will be exactly like what we imagine God to be.
When Will is fatally wounded by a group of anti-technology revolutionaries, his colleague-wife Evelyn (Rebecca Hall) and his best friend and fellow scientist Max Walters (Paul Bettany), who has been doing advanced research into artificial intelligence, make the bold decision to upload his brain into the quantum computer on which he's been working.
Once merged with the computer - indeed, all the computers in the world via the internet - Will takes steps not just to protect himself from the luddite revolutionaries and the American government, who are worried what he might do. He creates a command centre in a sleepy desert town with the aid of the devoted Evelyn, using millions plucked from the stockmarket to set up a laboratory that will allow him to realise his dream of solving all of mankind's ills - pollution, disease, even mortality - with his new God-like power.
The idea of a man merging his personality with a computer is fascinating. It brings into focus some of the most pressing issues of the day, such as what happens to our humanity in the face of cold logic, be it machines or the marketplace.
However, Depp is such a bland performer when not playing loveable crackpots he virtually disappears in Transcendence, leaving an emotional and intellectual hole at the centre of an otherwise polished, handsome- looking movie, the directorial debut of Christopher Nolan's regular cinematographer Wally Pfister.
More here:
Brand New 2014 GMC Terrain SLE for sale in Medicine Hat
http://www.davisgmctrucks.ca Toll Free 1-855-250-6606 http://inventory.davisgmctrucks.ca/new/vehicle/2014-gmc-terrain-id477769.htm Check out our inventory online or visit our showroom today!...
By: Davis GMC Buick
Read the original post:
Brand New 2014 GMC Terrain SLE for sale in Medicine Hat - Video
Medicine- Ross Aitken Choreography
3rd Overall Elite Large Group Choreography: Ross Aitken Contact: Rossaitken105@hotmail.com Instagram http://instagram.com/rossaitken_ Facebook https://www.facebook.com/RossAitken105?ref=tn_tnmn...
By: Ross Aitken
Go here to see the original:
Philip W. Brickner MD, Department of Community Medicine St. Vincent #39;s Hospital, New York
Philip W. Brickner MD - Last staff meeting as Chairman of The Department of Community Medicine St. Vincent #39;s hospital, New York.
By: Nell Eakin
Go here to see the original:
Philip W. Brickner MD, Department of Community Medicine St. Vincent's Hospital, New York - Video
Arizona Business Today Interviews Athletic Institute of Medicine
By: ArizonaBusinessToday
More here:
Arizona Business Today Interviews Athletic Institute of Medicine - Video
Dr. Faith Fitzgerald, UC Davis School of Medicine
This is a March 2014 presentation by Faith T. Fitzgerald, professor of internal medicine at UC Davis School of Medicine. Dr.Fitzgerald is a nationally recognized master educator and diagnostician...
By: UC Davis Health System
See original here:
DT15 - Wagon Wheel - Old Crow Medicine Show cover by Dusty Tracks
I forgot my music and my microphone so this recording at Linda #39;s house was through the built-in mic on my MacBook Pro.
By: George Possley
Read the original post:
DT15 - Wagon Wheel - Old Crow Medicine Show cover by Dusty Tracks - Video
Pronounce Medical Words Integrative Medicine
This video shows you how to say Integrative Medicine. How would you pronounce Integrative Medicine?
By: Medical 101
Read more: